ORUM THERAPEUTICS Trademark

Trademark Overview

On Friday, August 6, 2021, a trademark application was filed for ORUM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ORUM THERAPEUTICS trademark a serial number of 90869019. The federal status of this trademark filing is REGISTERED as of Tuesday, December 17, 2024. This trademark is owned by Orum Therapeutics, Inc.. The ORUM THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development of vaccines and medicines; drug discovery services; research on the subject of pharmaceuticals; pharmaceutical products evaluation; medical laboratory services; scientific research for medical purposes in the field of cancerous and immunological diseases; medical research laboratory services for predicting disease; scientific investigations for medical purposes; pharmaceutical product evaluation; medical product testing; biotechnology research; advisory services relating to biotechnology; research and development in the biotechnology field; biological laboratory services; biological research; development of biologics; design of biologics; research of biologics; biological surveys in the field of pharmaceutical research
orum therapeutics

General Information

Serial Number90869019
Word MarkORUM THERAPEUTICS
Filing DateFriday, August 6, 2021
Status700 - REGISTERED
Status DateTuesday, December 17, 2024
Registration Number7614215
Registration DateTuesday, December 17, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 14, "FIRST USE 9-15-2013; IN COMMERCE 9-15-2013" should be deleted, and "FIRST USE 9-15-2016; IN COMMERCE 9-15-2016" should be inserted.
NOT AVAILABLE"THERAPEUTICS"
Goods and Servicesresearch and development of vaccines and medicines; drug discovery services; research on the subject of pharmaceuticals; pharmaceutical products evaluation; medical laboratory services; scientific research for medical purposes in the field of cancerous and immunological diseases; medical research laboratory services for predicting disease; scientific investigations for medical purposes; pharmaceutical product evaluation; medical product testing; biotechnology research; advisory services relating to biotechnology; research and development in the biotechnology field; biological laboratory services; biological research; development of biologics; design of biologics; research of biologics; biological surveys in the field of pharmaceutical research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code042
First Use Anywhere DateThursday, September 15, 2016
First Use In Commerce DateThursday, September 15, 2016

Trademark Owner History

Party NameOrum Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDaejeon 34050
KR
Party NameOrum Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDaejeon 34050
KR
Party NameOrum Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDaejeon 34050
KR

Trademark Events

Event DateEvent Description
Tuesday, August 10, 2021NEW APPLICATION ENTERED
Tuesday, May 3, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 3, 2022ASSIGNED TO EXAMINER
Tuesday, May 3, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 2, 2023SOU EXTENSION 1 FILED
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 2, 2023SOU EXTENSION 1 GRANTED
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Saturday, March 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2023SOU EXTENSION 2 FILED
Thursday, September 7, 2023SOU EXTENSION 2 GRANTED
Wednesday, March 6, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 6, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 6, 2024SOU EXTENSION 3 FILED
Thursday, September 12, 2024USE AMENDMENT FILED
Thursday, September 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 12, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, November 14, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 14, 2024SOU EXTENSION 4 GRANTED
Thursday, November 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 25, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 17, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 17, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, January 23, 2025TEAS SECTION 7 REQUEST RECEIVED
Tuesday, June 17, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 15, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Tuesday, June 24, 2025CORRECTION UNDER SECTION 7 - PROCESSED

Related Keywords

therapeutics orum research services medical pharmaceutical field biotechnology development biologics biological laboratory